	US 12,129,499 B2
	Protease variants and uses thereof
Nathan Higginson-Scott, Hingham, MA (US); Nathan Rollins, Boston, MA (US); Jordan Anderson, Cambridge, MA (US); Alex Pellerin, Boston, MA (US); Ryan Peckner, Berkeley, CA (US); Yi Xing, Andover, MA (US); Ivan Mascanfroni, Worcester, MA (US); Kevin Lewis Otipoby, Ashland, MA (US); and Yanfeng Zhou, Boxborough, MA (US)
Assigned to Seismic Therapeutic, Inc., Watertown, MA (US)
Filed by Seismic Therapeutic, Inc., Cambridge, MA (US)
Filed on Jan. 5, 2024, as Appl. No. 18/405,861.
Prior Publication US 2024/0229002 A1, Jul. 11, 2024
Int. Cl. C12N 9/64 (2006.01); A61K 38/00 (2006.01); A61P 37/06 (2006.01)

CPC C12N 9/641 (2013.01) [A61P 37/06 (2018.01); A61K 38/00 (2013.01); C07K 2319/30 (2013.01); C07K 2319/50 (2013.01)]

25 Claims

1. A polypeptide comprising the amino acid sequence of SEQ ID NO: 1303.